Format

Send to

Choose Destination
Cancer Radiother. 2016 Oct;20(6-7):530-4. doi: 10.1016/j.canrad.2016.07.090. Epub 2016 Sep 7.

[Radiotherapy in localized stages of follicular and diffuse non-Hodgkin's lymphomas].

[Article in French]

Author information

1
Inserm, UMRS 1018, institut Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif, France.
2
Département d'oncologie médicale, institut de cancérologie de l'Ouest-René-Gauducheau, boulevard Jacques-Monod, 44800 Saint-Herblain, France.
3
Centre universitaire de cancérologie Henry-s-Kaplan, CHU, 37000 Tours, France.
4
Département de radiothérapie, institut de cancérologie de l'Ouest-René-Gauducheau, boulevard Jacques-Monod, 44800 Saint-Herblain, France. Electronic address: marc-andre.mahe@ico.unicancer.fr.

Abstract

Treatment with monoclonal antibodies, especially rituximab, is more and more frequent and questions the interest of radiotherapy in limited stages of diffuse B-cell large cell and follicular non-Hodgkin's lymphomas. From a review of literature, it appears that radiotherapy is of interest in bulky disease, patients with incomplete metabolic response, elderly patients receiving short chemotherapy and those with recurrence after exclusive chemotherapy. Finally, this article gives recommendations on available techniques of radiotherapy and doses to be delivered.

KEYWORDS:

Diffuse B-cell lymphomas; Follicular lymphomas; Lymphomes B diffuse à grandes cellules; Lymphomes folliculaires; Lymphomes non hodgkiniens; Non-Hodgkin's lymphomas; Radiotherapy; Radiothérapie; Rituximab

PMID:
27614527
DOI:
10.1016/j.canrad.2016.07.090
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center